UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015682
Receipt number R000018229
Scientific Title Double-blind, placebo-controlled study for the effect of rutin-rich processed buckwheat (Manten-kirari) on dyslipidemia and antioxidant
Date of disclosure of the study information 2014/11/13
Last modified on 2016/10/28 09:07:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Double-blind, placebo-controlled study for the effect of rutin-rich processed buckwheat (Manten-kirari) on dyslipidemia and antioxidant

Acronym

Effect of rutin-rich buckwheat on dyslipidemia and antioxidant

Scientific Title

Double-blind, placebo-controlled study for the effect of rutin-rich processed buckwheat (Manten-kirari) on dyslipidemia and antioxidant

Scientific Title:Acronym

Effect of rutin-rich buckwheat on dyslipidemia and antioxidant

Region

Japan


Condition

Condition

dyslipidemia

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to evaluate the effect of rutin-rich buckwheat(Manten-kirari) on dyslipidemia and antioxidant by double-blind, placebo-controlled study

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

arteriosclerosis index, oxo-LDL

Key secondary outcomes

T-Cho, LDL-Cho, HDL-Cho, TG, fasting blood glucose, HbA1c, Insulin, hs-CRP, apolipoprotein(B,A-1,E), adiponectin, TBARS, SOD, 8-OHdG, body weight, BMI, body fat rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake 80g of rehydratable noodle containing 50% rutin-rich buckwheat powder daily for 12 weeks.

Interventions/Control_2

Intake 80g rehydratable noodle lack of rutin-rich buckwheat powder daily for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Subjects whose arteriosclerosis index are between 1.5 and 4.5.
(2)Subjects who agree to participate in the current study with written informed consent.

Key exclusion criteria

(1) Subjects who are under medication for chronic ailments.
(2) Subjects with serious diseases and infections.
(3) Subjects with clinical history of gastrointestinal surgery.
(4) Subjects with frequent complaints of post-menopausal symptoms.
(5) Subjects with Familial hypercholesterolemia.
(6)Subjects with unusually high and/or low blood pressure, or with abnormal hematological data.
(7) Subjects with serious anemia.
(8)Subjects with a history of allergy to medicine and food, especially buckwheat and wheat
(9) Subjects routinely on supplementation which would affect lipid metabolism.
(10) Subjects routinely on supplementation which would affect blood pressure.
(11) Heavy smokers and alcohol addicts, or subjects with irregular lifestyle.
(12) Subjects who donate 400ml whole blood within 12 weeks or who donate plasma or platelets within 4 weeks prior to supplementation.
(13) Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study.
(12) Subjects who participate in other clinical trials within the last one month prior to the current clinical trial.
(13) Subjects who are not eligible due to physician's judgment

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Prof. Jun Nishihira, M.D.

Organization

Hokkaido Information University

Division name

Department of Medical Management and Informatics

Zip code


Address

59-2, nishi-nopporo, ebetsu, 069-8585, Hokkaido

TEL

011-385-4411

Email

nishihira@do-johodai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Dir. Prof. Jun Nishihira, M.D.

Organization

Hokkaido Information University

Division name

Health Information Science Center

Zip code


Address

59-2, Nishi-nopporo, Ebetsu, 069-8585, Hokkaido

TEL

011-385-4430

Homepage URL


Email

nishihira@do-johodai.ac.jp


Sponsor or person

Institute

Hokkaido Information University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Agriculture, Forestry and Fisheries

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Hokkaido university faculty
of agriculture
National Agriculture and Food
Research Organization for Hokkaido
Region
Kobayashi Foods co,Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海総情報大学 保健センター(北海道)


Other administrative information

Date of disclosure of the study information

2014 Year 11 Month 13 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://www.sciencedirect.com/science/article/pii/S1756464616302122

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 10 Month 27 Day

Date of IRB


Anticipated trial start date

2014 Year 12 Month 17 Day

Last follow-up date

2015 Year 04 Month 26 Day

Date of closure to data entry

2015 Year 08 Month 19 Day

Date trial data considered complete

2015 Year 08 Month 26 Day

Date analysis concluded

2016 Year 02 Month 02 Day


Other

Other related information



Management information

Registered date

2014 Year 11 Month 13 Day

Last modified on

2016 Year 10 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018229


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name